Current situation and development of prenatal diagnosis in China
- First Online:
Prenatal screening and diagnosis are major methods for control of birth defects, which is a very important problem in China. Here, we review current situation and development of prenatal screening and diagnosis in mainland China, including prenatal screening and prenatal diagnosis of fetal chromosome abnormalities, non-invasive prenatal diagnostic techniques and prenatal diagnosis of monogenic diseases, polygenic disease and congenital metabolic diseases. We also discuss epidemiology of birth defects and genetic diseases in China and related ethical issues of prenatal diagnosis.
Keywordsprenatal diagnosis prenatal screening China
Unable to display preview. Download preview PDF.
- 1.Bian XM, Liu J T, Qi Q W, Jiang Y L, Li Y, Liu S Y, Hao N, Zhou J, Lü SM, Zhu B S, Wang H, Xu Z F, Pan X Y, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu Y L. Second trimester maternal serum screening for Down’s syndrome in mainland China: a multi-center prospective study. Zhonghua Fu Chan Ke Za Zhi, 2008, 43(11): 805–809 (in Chinese)PubMedGoogle Scholar
- 4.Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, Timor-Tritsch I E, Carr S R, Wolfe H M, Dukes K, Bianchi D W, Rudnicka A R, Hackshaw A K, Lambert-Messerlian G, Wald N J, D’Alton M E; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down’s syndrome. New Engl J Med, 2005, 353(19): 2001–2011CrossRefPubMedGoogle Scholar
- 8.Zeng F, Ren Z R, Huang S Z, Kalf M, Mommersteeg M, Smit M, White S, Jin C L, Xu M, Zhou D W, Yan J B, Chen M J, van Beuningen R, Huang S Z, den Dunnen J, Zeng Y T, Wu Y. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients. Hum Mutat, 2008, 29(1): 190–197CrossRefPubMedGoogle Scholar